NCT02873962 A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02867384 Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT02865811 Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT02865135 Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02853500 Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies Status WITHDRAWN Phase PHASE4
NCT02852655 A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02848989 Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors Status COMPLETED Phase NA
NCT02827773 Improving Medication Adherence: A Study With Talking Pill Bottles Status COMPLETED Phase NA
NCT02823262 A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older Status TERMINATED Phase NA
NCT02816697 Implementation of a System-level Tobacco Treatment Intervention Status COMPLETED Phase NA
NCT02795858 A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors Status COMPLETED Phase PHASE2
NCT02787369 ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02783625 Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas Status COMPLETED Phase PHASE1
NCT02770014 Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer Status TERMINATED Phase PHASE2
NCT02766465 Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) Status COMPLETED Phase PHASE2
NCT02764541 Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) Status ACTIVE_NOT_RECRUITING Phase PHASE2